IDH3A and glioblastoma: Despite multimodal treatment including supramarginal resection, radiotherapy and chemotherapy isocitrate dehydrogenase (IDH)-wildtype glioblastoma (GBM), the most common malignant primary brain tumor has a median survival of less than two years [1,2].